(RTTNews) - Precision BioSciences, Inc. (DTIL) announced Wednesday that the U.S. Food and Drug Administration or FDA has granted Rare Pediatric Disease Designation for PBGENE-DMD, the company's ...

Following a second patient death, Sarepta is temporarily suspending use of Elevidys in non-ambulatory DMD patients, pending evaluation of an enhanced immunosuppression regimen.

RegenXBio has share | RegenXBio has shared updated phase 1/2 data on its Duchenne muscular dystrophy (DMD) gene therapy, providing evidence that its pivotal dose improves functional outcomes in ...

In order to accelerate development of PBGENE-DMD and maintain operational capability to pursue PBGENE-HBV and PBGENE-DMD through Phase 1 clinical results, Precision plans to pause development of ...

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts before deciding on the company's cell therapy for a heart condition ...

This cheap Android Auto adapter was the best thing I ever bought for my car You don't need to drop mountains of cash for wireless Android Auto, and this adapter proves it.

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure after being treated with Elevidys, the only gene therapy that has won ...

Ford fulfilled its promise and has now sent out all 140,000 complementary NACS adapters, unlocking access to Tesla Superchargers for its EV drivers.